Joanne K. Liu
A5102992660- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Hepatitis B Virus Studies
- RNA Interference and Gene Delivery
- Liver Disease and Transplantation
- SARS-CoV-2 detection and testing
- Advanced biosensing and bioanalysis techniques
- Liver Diseases and Immunity
- Systemic Lupus Erythematosus Research
- Biosensors and Analytical Detection
- Extracellular vesicles in disease
- MicroRNA in disease regulation
University of Washington
2022-2025
Stanford Medicine
2023-2025
Stanford University
2023-2025
Second Affiliated Hospital of Xi'an Jiaotong University
2024
Kaohsiung Medical University
2024
National Sun Yat-sen University
2024
There are limited data on antiviral treatment
Given the rise of metabolic diseases, we investigated their long-term impact in chronic hepatitis B (CHB) patients receiving nucleos(t)ide analogue (NA). We analyzed data from CHB who initiated NAs 30 centers (7 countries/regions). balanced patient characteristics with and without disease (diabetes, obesity, dyslipidemia, hypertension) via propensity-score matching (PSM) to evaluate adverse liver events motality. The study included 4,500 (54.6% ≥1 disease). PSM yielded 909 pairs...
As practice patterns and hepatitis C virus (HCV) genotypes (GT) vary geographically, a global real-world study from both East West covering all GTs can help inform policy toward the 2030 HCV elimination goal. This aimed to assess effectiveness tolerability of DAA treatment in routine clinical multinational cohort for patients infected with GTs, focusing on GT3 GT6.